Chronic schizophrenia

Search with Google Search with Bing
Information
Disease name
Chronic schizophrenia
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03275909 Completed N/A Integrated Psychological Therapy for Chronic Schizophrenia July 1, 2011 December 31, 2015
NCT00161044 Completed N/A An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms September 2004 September 2005
NCT06206798 Completed N/A Resourcefulness Group Intervention on Recovery and Quality of Life June 6, 2022 September 14, 2022
NCT05809882 Completed N/A Study of Experience of High-frequency Repetitive Transcranial March 1, 2019 February 20, 2020
NCT00789698 Completed Phase 3 Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia December 2008 July 2011
NCT01450514 Completed Phase 2 POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia March 2012 December 2012
NCT01761383 Completed N/A Role of Nintendo Wii in Improving Negative Symptoms and Quality of Life in Chronic Schizophrenia June 2012 January 2015
NCT01891929 Completed N/A Cognitive Remediation and Sheltered Employment in Schizophrenia July 2013 October 22, 2018
NCT02298985 Completed Phase 4 Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients January 2015 May 2017
NCT02421146 Completed N/A The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study April 2015 September 12, 2016
NCT02624167 Completed Phase 2 A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia December 2015 January 2017
NCT06349369 Recruiting N/A Effect of tDCS on Inflammatory Biomarkers in Chronic Schizophrenia April 8, 2024 April 9, 2026
NCT05948696 Recruiting Experience of Horticultural Group Therapy Among People With Chronic Schizophrenia June 6, 2023 September 29, 2023
NCT00148616 Terminated Phase 3 Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia April 2004 December 2008
NCT00525863 Unknown status Phase 3 Oxygen Therapy in Schizophrenia January 2008 December 2009
NCT00664274 Unknown status N/A Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia April 2007 October 2016